1. |
Hagan JP, Croce CM. MicroRNAs in carcinogenesis[J]. Cytogenet Genome Res, 2007, 118(2-4): 252-259.
|
2. |
Calin GA, Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer, 2006, 6(1): 857-866.
|
3. |
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci USA, 2004, 101(9): 2999-3004.
|
4. |
Cummins JM, He Y, Leary RJ, et al. The colorectal microRNAome[J]. Proc Natl Acad Sci USA, 2006, 103(10): 3687-3692.
|
5. |
Zeng Y, Wagner EJ, Cullen BR. Both natural and designed miRNAs can inhibit the expression of cognate mRNAs when expressed in human cells[J]. Mol Cell, 2002, 9(6): 1327-1333.
|
6. |
Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms[J]. Proc Natl Acad Sci USA, 2003, 100(17): 9779-9784.
|
7. |
Wiemer EA. The role of microRNAs in cancer: no small matter[J]. Eur J Cancer, 2007, 43(10): 1529-1544.
|
8. |
Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Cancer Res, 2005, 65(16): 7065-7070.
|
9. |
Ambs S, Prueitt RL, Yi M, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer[J]. Cancer Res, 2008, 68(15): 6162-6170.
|
10. |
Tong AW, Fulgham P, Jay C, et al. MicroRNA profile analysis of human prostate cancers[J]. Cancer Gene Ther, 2009, 16(3): 206-216.
|
11. |
Porkka KP, Pfeiffer MJ, Waltering KK, et al. MicroRNA expression profiling in prostate cancer[J]. Cancer Res, 2007, 67(13): 6130-6135.
|
12. |
Sun R, Fu X, Li Y, et al. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours[J]. BMC Genomics, 2009, 10: 93.
|
13. |
Varambally S, Cao Q, Mani RS, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer[J]. Science, 2008, 322(5908): 1695-1699.
|
14. |
Raveche ES, Salerno E, Scaglione BJ, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice[J]. Blood, 2007, 109(12): 5079-5086.
|
15. |
Linsley PS, Schelter J, Burchard J, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progession[J]. Mol Cell Biol, 2007, 27(6): 2240-2252.
|
16. |
Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b[J]. J Biol Chem, 2007, 282(2): 1479-1486.
|
17. |
Gandellini P, Folini M, Longoni N, et al. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CE[J]. Cancer Res, 2009, 69(6): 2287-2295.
|
18. |
Johnson SM, Grosshan SH, Shingara J, et al. RAS is regulated by the let-7 microRNA family[J]. Cell, 2005, 120(5): 635-647.
|
19. |
Prueitt RL, Yi M, Hudson RS, et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer[J]. Prostate, 2008, 68(11): 1152-1164.
|
20. |
Leite KR, Sousa-Canavez JM, Reis ST, et al. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis[J/OL]. Urol Oncol, 2009 Apr 15.[Epub ahead of print].
|
21. |
Zhang B, Pan X, Cobb GP, et al. MicroRNAs as oncogenes and tumor suppressors[J]. Dev Biol, 2007, 302(1): 1-12.
|
22. |
Musiyenko A, Bitko V, Barik S, et al. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells[J]. J Mol Med, 2008, 86(3): 313-322.
|
23. |
Lin SL, Chiang A, Chang D, et al. Lossofmir-146a function in hormone-refractory prostate cancer[J]. RNA, 2008, 14(3): 417-424.
|
24. |
Shi XB, Xue L, Yang J, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells[J]. Proc Natl Acad Sci USA, 2007, 104(50): 19983-19988.
|
25. |
Sun T, Wang Q, Balk S, et al. The Role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines[J]. Cancer Res, 2009, 69(8): 3356-3363.
|
26. |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci USA, 2008, 105(30): 10513-10518.
|
27. |
Siva AC, Nelson LJ, Fleischer CL, et al. Molecular assays for the detection of microRNAs in prostate cancer[J]. Mol Cancer, 2009, 8(1): 17.
|
28. |
Mattie MD, Benz CC, Bowers J, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies[J]. Mol Cancer 2006, 5: 24.
|
29. |
Fujita Y, Kojima K, Hamada N, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells[J]. Biochem Biophys Res Commun, 2008, 377(1): 114-119.
|
30. |
Lin SL, Chiang A, Chang D, et al. Loss of mir-146a function in hormone-refractory prostate cancer[J]. RNA, 2008, 14(3): 417-424.
|